baber/WOPTO huggingface dataset:
Patent NZ-506324-A (NZ)
Title: Ant  fungal  melanisation treatment of  logs  with  an antisapstain agent and a fumigant within 10 days of felling
Inventor: WAKELING ROBIN NICHOLAS
IPC: A01M7/00
Filed: 2000-08-14
Abstract: Described is a method for treating logs of felled trees against  sapstain,  that  may be  applied  later  than  some conventional anti-sapstain treatments and yet still  provide effective inhibition of sapstain development. Treating a log or piece of sawn timber includes steps of: (a) exposing the log or timber piece to a fumigant effective against any existing sapstain fungi; and (b) applying an anti-sapstain treatment to the log or timber piece to inhibit re-growth or infection of sapstain fungi. Preferably  the method includes exposing the log  or  timber piece  to the fumigant prior to melanisation of any existing sapstain fungi. Typically the log or timber piece will have a sapstain level of  less  than 10%, more preferably less than  5%  and  most preferably less than 1% at the time of treatment.
Patent NZ-511205-A (NZ)
Title: Electromagnetic device and driver circuit
Inventor: IWASAKI GUNCHU
IPC: H04W88/02
Filed: 2000-04-11
Abstract: An electromagnetic device is provided with a coil bobbin (1) supporting an excitation coil (5) and a U-shaped movable iron piece (2) whose one side (2a) is inserted in and fixed to a hollow section (la) of the coil bobbin (1) in a state where it is held between a pair of iron cores (3) and (4). A remaining side (2b) of the U-shaped movable iron piece (2) is inserted in a through-hole section (1c) of the coil bobbin (1) and has a resilient characteristic that it is spaced away from the one side (2a). The top surface of each of rising sections (3a) and (3b) of the iron cores (3) and (4) is configured by bending the end of each of the rising sections (3a) and (3b) and is located to be opposite to the top of the remaining side (2b) at a preset distance away.
Patent NZ-515462-A (NZ)
Title: Method for separating analogous organic compounds
Inventor: NISHIHARA YUTAKA
IPC: B01J39/04
Filed: 2000-05-19
Abstract: The application discloses a method for separating a lactone-containing high molecular weight compound having an alkyl group as its side chain from a lactone containing high-molecular weight compound having an alkenyl group as its side chain. The lactone-containing high-molecular weight compounds have a common basic chemical structure, by using a sulfonic acid group-containing strong cation exchange resin pre-treated with silver ions.
Patent NZ-521933-A (NZ)
Title: Hedging exchange traded mutual funds or other portfolio basket products
Inventor: GASTINEAU GARY L
IPC: G06Q40/00
Filed: 2001-03-26
Abstract: A method of hedging investment risk in actively managed exchange traded funds, comprises : receiving or determining factor information about the fund holdings, wherein a computer programmed with factor analysis software determines the factor information , which measures the sensitivity of the fund holdings to factors that affect the value of the fund holdings, and using a computer with the factor information as an input to select a portfolio of financial instruments to produce a hedging portfolio with substantially the same sensitivity to the factors that affect the value the value of the fund holdings.
Patent NZ-522937-A (NZ)
Title: UV curable composition for forming a scratch-off layer
Inventor: VUARNOZ ALINE
IPC: C09D11/101
Filed: 2001-06-01
Abstract: A coating composition for forming a scratch-off layers on substrates which are removable upon scratching after being curing by UV radiation is disclosed, wherein the composition comprises: a) film forming components, comprising (i) at least on first organic molecule containing an epoxy-group, and (ii) at least one second organic molecule containing a nucleophilic group, the second organic molecule being crosslinkable with the first organic molecule through chemical reaction of nucleophilic and epoxy groups; b) components being insoluble in the coating composition, the components comprising at least one pigment; c) at least one photo initiator to initiate the reaction between the first and second organic molecule upon irradiation with electromagnetic radiation preferably in the ultraviolet range; d) optionally, further additives; and e) optionally, solvent wherein the weight ratio (r) of the film forming components to the insoluble components is in the range of between 0.35 to 0.95, the composition to be cured by reaction of the first and second organic molecule to form the scratch-off layer.
Patent NZ-523305-A (NZ)
Title: Geographic view of a modelling system
Inventor: ANDERSON MARK STEPHEN
IPC: G06T11/20
Filed: 2002-04-30
Abstract: Geo View is a three-dimensional virtual universe in which a real-world or virtual object may be represented by one or more virtual objects whose attributes are derived from attributes of the real-world object via a flexible user-specifiable mapping. Typically a two-dimensional plane located in three-dimensional space is used to visualise the universe of interest. The placement of virtual objects in the universe typically having a shape is governed by the absolute or relative geographical location of the real-world objects, and also by a flexible set of user-specified layout rules. In addition to the visualisation of various objects, the human observer can attach sounds to objects. The representation of real-world objects with rapidly time-changing attributes may be simplified by the use of Synthetic Strobes, flexible user-specified filters which shift changes in the visual attributes of a shape from one time-domain to another.
Patent NZ-527872-A (NZ)
Title: Composition and methods for modulation of vascular structure and/or function with a material comprising semi- crystalline poly-beta-1-4 N-acetylglucosasmine (p-GlcNac) polymers
Inventor: VOURNAKIS JOHN N
IPC: A61K9/10
Filed: 2002-02-08
Abstract: A composition is disclosed which consists of an amount of a non-barrier forming material, in the form of a solution, suspension, emulsion, spray, or foam, with semi-crystalline beta-1-4-N-acetylglucosamine polymers (p-GlcNac). The medicament is to be topically administered to a patient in need of modulation, as it is useful for stimulating, in a p-GlcNac concentration-dependent manner, endothelin-1-release, vasoconstriction, and/or reduction in blood flow out of a breached vessel, as well as for contributing to or effecting cessation of bleeding. The amount used is to be sufficient for achieving at least a transient, localised physiological response whereby at least a transient, localised modulation of vascular structure and/or function is achieved. The medicament is explained to be beneficial in treating vascular disorder such as menorrhagia, cerebral aneurysm, abdominal aneurysm, uterine fibroid lesion, and blood vessel puncture.
Patent NZ-528253-A (NZ)
Title: Unit for preparing beverages from soluble products
Inventor: MAJER DOGLIONI LUCA
IPC: A47J31/40
Filed: 2001-03-23
Abstract: It is disclosed a unit (1) for the preparation of a beverage from a soluble product contained in a disposable cartridge (2), of the type comprising a collecting device (3) with a seat designed to contain the cartridge, wherein at least one throttling arrangement is provided to ensure laminar flow of the beverage as it comes out from the cartridge.
Patent NZ-529709-A (NZ)
Title: Acetabular prosthesis assembly
Inventor: SEKEL RONALD
IPC: A61F2/30
Filed: 2002-04-26
Abstract: An acetabular prosthesis assembly (1) comprising an acetabular cup (3) with a generally convex outer surface for engaging acetabular bone and a generally concave inner surface, an insert (10) capable of insertion in the cup (3) for receiving a femoral head component, wherein a wear liner (13) is disposed between the cup (3) and the insert (10), the liner (13) providing a wear inhibiting surface (4a).
Patent NZ-531246-A (NZ)
Title: Substituted benzimidazole compounds and their use for the treatment of cancer
Inventor: CLERC FRANCOIS
IPC: A61K31/496
Filed: 2002-09-26
Abstract: Disclosed are compounds of formula (I), wherein: A is phenyl, R1 is optionally substituted, alkoxy, aryl or heteroaryl, halogen, 4NH2, 4NH alkyl or cycloalkyl optionally substituted with an acyl, an acylderivative, hydroxy, an amino, alkoxy, heterocyclyl or aryl; 4N imidazolyl, or 3SO2Me, R2 is optionally substituted CO-alkyl, CO-aralkyl, CO-aryl, CO-alkoxy, CO-amino, CO-NHR3, CO-NR3R4, aryl or aralkyl. The compounds are used for the preparation of medicaments for use in treating cancer diseases.
Patent NZ-531814-A (NZ)
Title: Vaccines
Inventor: BEATON ANDREW
IPC: A61K39/00
Filed: 2002-09-18
Abstract: A nucleotide sequence that encodes an HIV-1 gag protein or fragment containing a gag epitope thereof, an HIV-1 Nef protein or a fragment thereof containing a nef epitope and an RT protein or a fragment containing an RT epitope, operably linked to a heterologous promoter.
Patent NZ-533486-A (NZ)
Title: Substituted phenyl derivatives
Inventor: HELMKE HENDRICK
IPC: C07D231/20
Filed: 2002-11-25
Abstract: A compound of formula (I) is described wherein: A is a substituted pyridyl, thienyl or pyrazolyl of formula (a), (b) or (c); R15 is CH3, CH2F, CHF2, CF3, OCH3, OCH2F, OCHF2, OCF3 or CN; R15" is a (C1-C8)alkyl group X is O, S or CH2 R1 is hydroxyl, halogen, CN, NC, CHO, CO(C1-C8)alkyl, where the alkyl group is unsubstituted or substituted, CONH2, CSNH2, nitro, SF5, (C1-C8)alkyl, (C2-C8)alkenyl, (C2-C8)alkynyl, (C1-C8)alkoxy, [(C1-C8)alkyl]carbonyl or (C1-C8)alkylsulfonyl or S(O)pR3 where p is 0, 1 or 2, or R1 is a group of the formula C(=Z)Z1R6 where R6 is (C1-C8)alkyl and Z and Z1 are O or S R2 are identical or different radicals H, halogen, CN or (C1-C8)alkyl, which are unsubstituted or substituted, Y is O-(CR8R9)q, S(O)q, NH, CO(CR8R9)q or CR8R9 and, if B is a substituted or unsubstituted aryl radical, a substituted or unsubstituted heterocyclyl radical, halogen or CN, Y may also be a bond, B is an unsubstituted or substituted aryl radical, an unsubstituted or substituted heterocyclic radical, H, OH, halogen, CN, nitro, SF5, (C1-C8)alkyl, (C2-C8)alkenyl or (C2-C8)alkynyl, where the 3 last-mentioned radicals are unsubstituted or substituted, or an acyl radical or NR11R12, or CH2CH(QR14)Q1R13 wherein R13 and R14 are (C1-C8)alkyl which is unsubstituted or substituted, or together form a ring, Q and Q1 are O or S. The compounds can be used as herbicides or plant growth regulating compositions. Also described are methods of preparing the compounds.
Patent NZ-534429-A (NZ)
Title: Modular flooring system with framed tiles
Inventor: GRAU JEAN-PIERRE
Filed: 2003-01-07
Abstract: Disclosed is a flooring system comprising tiles (7), at least a series of identical and rigid slab framing modules (1, 8) in at least one plane, the framing modules of the series being complementary so as to be placed relative to one another for form an exposed grid of said slabs (7) and means for removably assembling together the modules, designed to impose a relative orientation of said modules and link them rigidly in one plane at least and to enable, once the flooring system is installed, to remove any one of the framing modules by manipulating only said framing module and, if required, only the adjacent slab(s) and or modules adjacent thereto.
Patent NZ-535148-A (NZ)
Title: HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
Inventor: SORENSEN BIRGER
IPC: G01N33/569
Filed: 2001-09-03
Abstract: Peptides derived from HIV-1 gag p24 protein comprise at least one amino acid sequence which contains modifications compared with the native sequence and is selected from the group of amino acid sequences: Xaa1 Ala Xaa3 Xaa4 Xaa5 Ala Xaa7 Xaa8 Xaa9 Leu Leu Xaa12 Xaa13 Xaa14 -Z- Xaa15 Xaa16 His Gln Xaa19 Ala Xaa21 Xaa22 (SEQ ID:9) wherein: Xaa in position 1 is Tyr, Trp, Phe or Gly; Xaa in position 3 is Thr, Ala, Val, Ile or Leu; Xaa in position 4 is Pro or Ser; Xaa in position 5 is Gln, His, Gly, Thr, Ser or Tyr; Xaa in position 7 is Leu, Ile or Val; Xaa in position 8 is Asn or Tyr; Xaa in position 9 is Thr, Met, Leu or Ala; Xaa in position 12 is Ser, Thr or Asn; Xaa in position 13 is Thr, Ile, Val or Ala; Xaa in position 14 is Val or Ile; Xaa in position 15 is Gly or none; Xaa in position 16 is Gly or none; Xaa in position 19 is Ala or Gly; Xaa in position 21 is Met, Leu, Cys or none; Xaa in position 22 is Gln, Glu, His, Gly or none; wherein the sequence of SEQ ID NO:9 consists of at least six consecutive amino acids and wherein the peptide contains Ala in position 6 and Leu in position 10, and the linker -Z- is optional and has the meaning PEG, modified PEG and/or [Gly]n, wherein n = 1, 2 or 3, the terminal ends of the sequences may be free carboxyl or amino groups, amides, acyls, acetyls or salts thereof, two or more Cys residues may form part of an interchain disulphide binding, a -S-(CH2)p-S- or a -(CH2)p-bridge wherein p = 1-8 optionally intervened by one or more the hetero atoms such as O, N and S and/or the said peptide sequences are immobilized to a solid support. Also described is an antigen comprises at least one of the peptides, a vaccine composition that comprises the antigen, a method of detecting antibodies induced by HIV or HIV-specific peptide(s) or protein(s) and an immunoassay kit for the detection of antibodies induced by HIV or HIV-specific peptides or proteins.
Patent NZ-537359-A (NZ)
Title: Topical cosmetic compositions for transdermal delivery
Inventor: GERVASIO-NUGENT CARLA
IPC: A61Q19/08
Filed: 2003-06-24
Abstract: A topical cosmetic composition including: at least one water-soluble cosmetic agent; at least two oil-soluble cosmetic agents; and a dermal penetration enhancer is disclosed, wherein topical application of the composition results in the delivery of the water-soluble and oil-soluble cosmetic agents into the stratum corneum as well as delivery of the oil-soluble cosmetic agent into the epidermis and dermis.
Patent NZ-537611-A (NZ)
Title: Composition comprising a cholesterol absorption inhibitor, an HMG-CoA reductase inhibitor and a stabilizing agent
Inventor: MOORE WILLIAM D
IPC: A61K45/06
Filed: 2003-07-22
Abstract: Disclosed is a pharmaceutical composition comprised of from 1% to 20% by weight of a cholesterol absorption inhibitor; from 1% to 80% by weight of simvastatin; from 0.01% to 2% by weight of at least one antioxidant agent; and citric acid up to a maximum of 10% by weight, provided that the composition is not comprised of ascorbic acid.
Patent NZ-541680-A (NZ)
Title: Use of bradykinin-B2 receptor antagonists for treating osteoarthrosis
Inventor: MICHAELIS MARTIN
IPC: A61K38/08
Filed: 2004-01-23
Abstract: Disclosed is the use of specific peptides that have a Bradykinin-antagonistic effect for the production of drugs for use in the prophylaxis and therapy of osteoarthrosis, spondylosis and chondroporosis after joint trauma.
Patent NZ-541774-A (NZ)
Title: Fastening system for attaching metal studs to metal track
Inventor: CARINGELLA ANTHONY R
Filed: 2005-08-15
Abstract: A new and improved fastening system for attaching relatively thin-gauge sheet metal members, such as, for example 14-25 gauge sheet metal members, wherein the power output parameters of the power tool are controlled such that when the driver blade member of the power tool acts upon each one of the brad-type nail fasteners, the brad-type nail fasteners will attain a predetermined velocity value, such as, for example, within the velocity range of 1000-2500 in/sec. Any one of various different types of power tools may be employed, and in addition, various geometrical characteristics of each brad-type fastener are important, such as, for example, the tip geometry, the aspect ratio A/R of the shank member of the fastener, and the use of an adhesive or painted coating upon the external surface areas of the shank member of the fastener. The fasteners preferably comprise dual-width fasteners which exhibit enhanced pull-out resistance values.
Patent NZ-542827-A (NZ)
Title: Process for preparing crystalline ciclesonide with defined particle size
Inventor: EISTETTER KLAUS
IPC: C07J71/00
Filed: 2004-03-26
Abstract: Disclosed is a process for preparing a compound of the formula I in crystalline form, a particle diameter for 50% of the total volume of all particles (X50) being in the range of from 1.8 to 2.0 micrometres, comprising the steps of a) preparation of a solution of the compound of the formula I in a suitable water-miscible organic solvent; b) adding the solution obtained as in a) to water and c) isolating the precipitate of the compound of the formula I which is formed. Also disclosed is a compound of the formula I in crystalline form having a particle diameter for 50% of the total volume of all particles (X50) in the range of from 1.8 to 2.0 micrometres. The crystalline ciclesonide forms are useful for topical application and for inhalable or nasally administered pharmaceutical preparations.
Patent NZ-545051-A (NZ)
Title: Distribution connecting module
Inventor: BUSSE RALF DIETER
IPC: H01R12/55
Filed: 2004-08-12
Abstract: The distribution connecting module (1) for telecommunications and data systems technology, comprises a housing (2) inside of which input and output contacts for connecting lines and wires are placed, said contacts being accessible from the exterior. The housing (2) is provided with a cavity inside of which at least one printed circuit board is placed. The input and output contacts are situated on the opposing faces of the housing (2). The input contacts are provided in the form of at least one connector strip (5) with insulation displacement contacts. The input and output contact can be detachably connected to the printed circuit board. The connector strip (5) supporting the input contacts is detachably connected to the housing (2) via a front part. The insulation displacement contacts are connected to the printed circuit board (6) via fork contacts. The connection between the front part and the housing (2) is such that when the connection is released, the connector strip (5), which is connected to the front part, is, together with the fork contacts, moved away from the printed circuit board.
Patent NZ-545748-A (NZ)
Title: Isoxazoline derivatives as inhibitors of phosphodiesterase type-IV
Inventor: PALLE VENKATA P
IPC: A61K31/42
Filed: 2004-08-30
Abstract: Disclosed is a compound of Formula I, or a pharmaceutically acceptable salt or solvate thereof, wherein X and Y are both oxygen, R1 and R2 may be separate substituents or may form a cycloalkyl ring as described, and wherein the rest of the substituents are as described in the specification.
Patent NZ-549516-A (NZ)
Title: Biodegradable intraocular implants containing prostamides
Inventor: HUGHES PATRICK M
IPC: A61K9/20
Filed: 2005-04-20
Abstract: Disclosed is a biodegradable intraocular implant comprising a prostamide component and a biodegradable polymer matrix that, releases drug at a rate effective to sustain release of a therapeutically effective amount of the prostamide component for at least one week after the Implant is placed in an eye, wherein the prostamide component comprises a cyclopentene, having the formula (I) wherein the dashed bonds represent a single or double bond which can be in the cis or trans configuration, A is an alkylene or alkenylene radical, which radical may be interrupted by one or more oxide radicals and substituted with one or more hydroxy, oxo, alkyloxy or akylcarboxy groups, B is a cycloalkyl radical, or an aryl radical, selected from the group consisting of hydrocarbyl aryl and heteraaryl wherein the heteroatom is selected from the group consisting of, nitrogen, oxygen and sulfur atoms and X is defined in the specification. Also disclosed is a method to make said implant.
Patent NZ-566023-A (NZ)
Title: Carboxamide derivatives as muscarinic receptor antagonists
Inventor: GLOSSOP PAUL ALAN
IPC: C07D413/12
Filed: 2006-09-01
Abstract: The disclosure relates to carboxamide compounds of Formula (I) wherein the substituents are defined as in the specification. Also disclosed are intermediates for their preparation, their use as muscarinic antagonists in the manufacture of medicaments for treatment of inflammation of airways and similar diseases and pharmaceutical composition containing them.
Patent NZ-569523-A (NZ)
Title: Dibenzene derivatives as calcium channel blockers
Inventor: MARTINEZ GIL ANA
IPC: C07C235/60
Filed: 2006-12-15
Abstract: The disclosure is directed to dibenzene derivative compounds of formula (I) having voltage-dependant calcium channel (VDCC) blocking activity, wherein the variables are as defined in the specification. These compounds are useful for the treatment of a series of human diseases and conditions, especially cognitive or neurodegenerative diseases or conditions selected from stroke, ischemia, anxiety, epilepsy, head trauma, migraine, chronic pain, neuropathic pain and acute pain, schizophrenia, depression, psychoses, drug and alcohol addiction, and neurodegenerative disorders such as Parkinson's Disease, Alzheimer's Disease, multiple sclerosis, neuropathies, Huntington's Disease and amyotrophic lateral sclerosis (ALS).
Patent NZ-571597-A (NZ)
Title: Method for preparing crystalline and crystal-like forms of purified daptomycin lipopeptides
Inventor: KEITH DENNIS
IPC: A23K20/195
Filed: 2001-12-17
Abstract: A crystalline or crystal-like divalent calcium salt of daptomycin is disclosed, wherein the crystal-like daptomycin is crystalline as determined visually, or by optical or polarizing microscopy or birefringence. Also disclosed is a pharmaceutical composition comprising a crystalline or crystal-like divalent calcium salt of daptomycin and a pharmaceutically acceptable carrier, and its use in the manufacture or preparation of a medicament. (62) Divided Out of 554405
Patent NZ-574642-A (NZ)
Title: A muffler that varies its characteristics by blocking one of two passages that has a lower resistance to flow
Inventor: FENG ZHANZHAO
IPC: F01N9/00
Filed: 2007-08-07
Abstract: Disclosed is a muffler assembly with two passages that can be open or closed to improve air flow to increase vehicle performance. The muffler assembly (10) for exhaust gas flow is in fluid communication with an engine exhaust. The assembly includes a muffler having inlet and outlet ports (14, 16). The assembly also includes first and second flow of passages in common fluid communication with the outlet port and in variable fluid communication with the inlet port. The first and second flow passages meet at first and second connecting points. The first connecting point is located in the proximity of the inlet port. The first flow passage has a higher resistance to fluid flow than the second flow passage. The assembly also includes a valve means (24) generally located past the first connecting point inside the second flow passage for selectively proportionating exhaust gases passing through the passages. The first flow passage includes three or more conduits (26, 28, 30) being in fluid communication with each other. No portion of any one of the three or more conduits is contained within any of the remaining conduits.
Patent NZ-574817-A (NZ)
Title: Water treatment method comprising topping up of ballast according to results from measurement sensor
Inventor: SAUVIGNET PHILIPPE
IPC: C02F1/52
Filed: 2007-07-25
Abstract: A water treatment system by means of flocculation is disclosed. The system comprises at least one inlet (1) for water to be treated, at least one flocculation tank (4) into which at least one flocculation reagent is injected via injection means (2) and a means for return of a ballast, such as fine sand, via an injection means (3). A setting tank (5) is provided with means for discharging clarified water (6) as well as a zone (51) for recovering a mixture of sludge and ballast. The system also includes a re-circulation line (7) and at least one measurement sensor (11). The measurement sensor(s) (11) uses comparison means for comparing the measurement of the concentration of ballast with predetermined values. The comparison means is coupled with ballast top-up injection means (3). In use, the ballast coming from a storage means gets activated/deactivated depending upon the comparison of the measurement value with predetermined value.